Botanical species · safety record
Mentha spicata
The EFSA Compendium of Botanicals holds 53 constituent measurements and 1 adverse-effect record for Mentha spicata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Mentha spicata L.
Also recorded as
Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.
Regulatory presence
Health Canada's Licensed Natural Health Products Database holds 103 licensed products naming Mentha spicata as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.
Extract types on licence
Source material stated
What the records describe
Constituents measured
- 1,8-cineole8
- Myrcene8
- Piperitenone oxide8
- Cis-piperitone epoxide7
- Trans-piperitone oxide6
- Carvone3
- Dihydrocarvone3
- Menthone3
- (+)-pulegone2
- D,l-isomenthone2
Plant parts
- Aerial part of plants23
- Leaves11
- Flowering top10
- Stem10
- stalk10
Preparations
- Essential oil53
- Solvent extraction1
Effect types
- Endocrine1
Target tissues
- Testes1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| (+)-pulegone | Aerial part of plants | Essential oil | 72.1 Percent | GC-MS | Resolve DOI |
| 1,8-cineole | Aerial part of plants | Essential oil | ≤ 7 Percent | GC-MS | Resolve DOI |
| 1,8-cineole | Aerial part of plants | Essential oil | ≥ 1 Percent | GC-MS | Resolve DOI |
| Carvone | Aerial part of plants | Essential oil | ≥ 59 Percent | GC-MS | Resolve DOI |
| Carvone | Aerial part of plants | Essential oil | 67.1 Percent | GC-MS | Resolve DOI |
| Carvone | Aerial part of plants | Essential oil | ≤ 77 Percent | GC-MS | Resolve DOI |
| Cis-piperitone epoxide | Aerial part of plants | Essential oil | 23.8 Percent | GC-MS | Resolve DOI |
| D,l-isomenthone | Aerial part of plants | Essential oil | 32 Percent | GC-MS | Resolve DOI |
| D,l-isomenthone | Aerial part of plants | Essential oil | 2.6 Percent | GC-MS | Resolve DOI |
| Dihydrocarvone | Aerial part of plants | Essential oil | ≤ 4 Percent | GC-MS | Resolve DOI |
| Dihydrocarvone | Aerial part of plants | Essential oil | ≥ 1 Percent | GC-MS | Resolve DOI |
| Dihydrocarvone | Aerial part of plants | Essential oil | 1 Percent | GC-MS | Resolve DOI |
| Menthone | Aerial part of plants | Essential oil | 15.6 Percent | GC-MS | Resolve DOI |
| Menthone | Aerial part of plants | Essential oil | 14 Percent | GC-MS | Resolve DOI |
| Myrcene | Aerial part of plants | Essential oil | 2.1 Percent | GC-MS | Resolve DOI |
| Piperitenone oxide | Aerial part of plants | Essential oil | 41 Percent | GC-MS | Resolve DOI |
| Piperitone oxide | Aerial part of plants | Essential oil | 30 Percent | GC-MS | Resolve DOI |
| (+)-pulegone | Aerial part of plants | Essential oil | — | GC-MS | No resolvable identifier |
| 1,8-cineole | Stem / stalk | Essential oil | ≤ 25.4 Percent | GC-MS | No resolvable identifier |
| 1,8-cineole | Stem / stalk | Essential oil | ≥ 13.6 Percent | GC-MS | No resolvable identifier |
| 1,8-cineole | Leaves | Essential oil | ≤ 40.5 Percent | GC-MS | No resolvable identifier |
| 1,8-cineole | Leaves | Essential oil | ≥ 11.9 Percent | GC-MS | No resolvable identifier |
| 1,8-cineole | Flowering top | Essential oil | ≤ 13.5 Percent | GC-MS | No resolvable identifier |
| 1,8-cineole | Flowering top | Essential oil | ≥ 3.5 Percent | GC-MS | No resolvable identifier |
| Cis-piperitone epoxide | Leaves | Essential oil | ≥ 1.5 Percent | GC-MS | No resolvable identifier |
| Cis-piperitone epoxide | Flowering top | Essential oil | ≤ 5.9 Percent | GC-MS | No resolvable identifier |
| Cis-piperitone epoxide | Stem / stalk | Essential oil | ≤ 7.8 Percent | GC-MS | No resolvable identifier |
| Cis-piperitone epoxide | Flowering top | Essential oil | ≥ 3 Percent | GC-MS | No resolvable identifier |
| Cis-piperitone epoxide | Stem / stalk | Essential oil | ≥ 3.3 Percent | GC-MS | No resolvable identifier |
| Cis-piperitone epoxide | Leaves | Essential oil | ≤ 5.9 Percent | GC-MS | No resolvable identifier |
| Menthofuran | Aerial part of plants | Essential oil | — | GC-MS | No resolvable identifier |
| Menthone | Aerial part of plants | Essential oil | — | GC-MS | No resolvable identifier |
| Myrcene | Stem / stalk | Essential oil | ≤ 13.5 Percent | GC-MS | No resolvable identifier |
| Myrcene | Stem / stalk | Essential oil | ≥ 4.5 Percent | GC-MS | No resolvable identifier |
| Myrcene | Leaves | Essential oil | ≤ 7.4 Percent | GC-MS | No resolvable identifier |
| Myrcene | Leaves | Essential oil | ≥ 2.7 Percent | GC-MS | No resolvable identifier |
| Myrcene | Flowering top | Essential oil | ≤ 6.7 Percent | GC-MS | No resolvable identifier |
| Myrcene | Flowering top | Essential oil | ≥ 2.9 Percent | GC-MS | No resolvable identifier |
| Myrcene | Aerial part of plants | Essential oil | — | GC-MS | No resolvable identifier |
| Piperitenone oxide | Stem / stalk | Essential oil | ≤ 24.8 Percent | GC-MS | No resolvable identifier |
40 of 53 records are shown, ordered so that records carrying a resolvable reference come first.
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| Endocrine | Testes | Leaves | Solvent extraction | Rat (as animal) | Reproduction toxicity | No resolvable identifier |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Sacco, Tommaso., Nano, Gian M. New plant for the essential oil literature. Botanical and chemical research. Rivista italiana essenze, profumi, piante officinali, aromi, saponi, cosmetici, aerosol, 1973, vol. 55, no. 4, p. 229-31.
- Cook, Catherine M., Kokkini, Stella., Lanaras, Thomas. Mentha spicata essential oils rich in 1,8-cineole and 1,2-epoxy-P-menthane derivatives from Zakynthos (Ionian Island, W Greece) . Journal of essential oil research, 2007, vol. 19, no. 3, p. 225-230.
- Koutroumanidou, Eleni., Kimbaris, Athanasios., Kortsaris, Alexandros., Bezirtzoglou, Eugenia., Polissiou, Moschos., Charalabopoulos, Konstantinos., Pagonopoulou, Olga. Increased seizure latency and decreased severity of pentylenetetrazol-induced seizures in mice after essential oil administration. . Epilepsy research and treatment, 2013, vol. 2013, p. 532657-532657. DOI
- Baser, K. H. C., Kurkcuoglu, M., Demirci, B., Ozek, T., Tarimcilar, G. Essential oils of Mentha species from Marmara region of Turkey. JOURNAL OF ESSENTIAL OIL RESEARCH, 2012, vol. 24, no. 3, p. 265-272. DOI
- Joshi, R. K. Pulegone and Menthone Chemotypes of Mentha spicata Linn. from Western Ghats Region of North West Karnataka, India . National academy science letters-india, 2013, vol. 36, no. 3, p. 349-352. DOI
- Nozhat, Fatemeh., Alaee, Sanaz., Behzadi, Khodabakhsh., Azadi Chegini, Najmeh. Evaluation of possible toxic effects of spearmint (Mentha spicata) on the reproductive system, fertility and number of offspring in adult male rats. . Avicenna journal of phytomedicine, 2014, vol. 4, no. 6, p. 420-9.
- Eliopoulos, P. A., Hassiotis, C. N., Andreadis, S. S., Porichi, A. -E. E. Fumigant Toxicity of Essential Oils from Basil and Spearmint Against Two Major Pyralid Pests of Stored Products. Journal of economic entomology, 2015, vol. 108, no. 2, p. 805-810. DOI
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.